Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711947/
https://www.ncbi.nlm.nih.gov/pubmed/36466556
http://dx.doi.org/10.1155/2022/9793601
_version_ 1784841687393107968
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-9711947
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-97119472022-12-01 Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2022-11-23 /pmc/articles/PMC9711947/ /pubmed/36466556 http://dx.doi.org/10.1155/2022/9793601 Text en Copyright © 2022 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
title Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
title_full Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
title_fullStr Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
title_full_unstemmed Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
title_short Retracted: Clinical Efficacy of Ulinastatin Combined with Meglumine Adenosine Cyclophosphate in the Treatment of Acute Myocardial Infarction
title_sort retracted: clinical efficacy of ulinastatin combined with meglumine adenosine cyclophosphate in the treatment of acute myocardial infarction
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711947/
https://www.ncbi.nlm.nih.gov/pubmed/36466556
http://dx.doi.org/10.1155/2022/9793601
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedclinicalefficacyofulinastatincombinedwithmeglumineadenosinecyclophosphateinthetreatmentofacutemyocardialinfarction

Ejemplares similares